Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hepatitis C
  Free Subscription

Articles published in
J Infect Dis
    April 2026
  1. SOLIMAN R, Hassan AA, Shiha G
    Rapid HCV diagnostics: aligning molecular innovation with real-world elimination needs.
    J Infect Dis. 2026 Apr 8:jiag207. doi: 10.1093.
    >> Share

  2. REED JL, Butzler MA, Hawkins CA, Manabe YC, et al
    Reply to Soliman et al, Rapid HCV diagnostics: aligning molecular innovation with real-world elimination needs.
    J Infect Dis. 2026 Apr 8:jiag208. doi: 10.1093.
    >> Share

    January 2026
  3. APPLEGATE TL, Grebely J
    When Time Is of the Essence: Hepatitis C Virus RNA Point-of-Care Testing in 15 Minutes Becomes a Reality.
    J Infect Dis. 2026 Jan 22:jiaf652. doi: 10.1093.
    >> Share

  4. WEN A
    CXCR6 in the Blood Is Not the Liver: Clarifying NK-Cell 'Homing' and Post-Cure ADCC Imprints in Acute Hepatitis C.
    J Infect Dis. 2026 Jan 21:jiag044. doi: 10.1093.
    >> Share

    December 2025
  5. STRUNZ B, Zhan Q, Khera T, Hengst J, et al
    Transient interferon-driven NK cell activation in acute hepatitis C.
    J Infect Dis. 2025 Dec 27:jiaf654. doi: 10.1093.
    >> Share

  6. CHOWDHURY A, Garcia BG, Zahoor MA, Fadl ElMawla N, et al
    A rapid assay for HCV RNA detection using RT-LAMP coupled CRISPR-Cas12b based strategy.
    J Infect Dis. 2025 Dec 16:jiaf609. doi: 10.1093.
    >> Share

  7. REED JL, Butzler MA, Hawkins CA, Manabe YC, et al
    Development of a Rapid Automated Point-of-Care Test for Hepatitis C Viral RNA on the DASH(R) Rapid PCR System.
    J Infect Dis. 2025 Dec 10:jiaf608. doi: 10.1093.
    >> Share

    October 2025
  8. SKOVGAARD ET, Wiggers T, Karsdal M, Goetze JP, et al
    Serum markers of fibroinflammatory activity PRO-C3 and CPa9-HNE are associated with liver-related outcomes in patients with Chronic Hepatitis C.
    J Infect Dis. 2025 Oct 31:jiaf552. doi: 10.1093.
    >> Share

    July 2025
  9. VO-QUANG E, Rodriguez C, Ly A, Ndow G, et al
    Virological tools fail to properly identify "unusual" hepatitis C virus subtypes resistant to direct-acting antiviral drugs in The Gambia.
    J Infect Dis. 2025 Jul 22:jiaf378. doi: 10.1093.
    >> Share

    May 2025
  10. WEGERMANN K, Lucas JE, Dubois L, Mangus R, et al
    Plasma lipid metabolites differentiate metabolic from viral chronic liver disease.
    J Infect Dis. 2025 May 23:jiaf270. doi: 10.1093.
    >> Share

  11. GRANTZ KH, Anantharam R, Kandathil AJ, Quinn J, et al
    Multiple approaches to genetic sequencing to identify hepatitis C virus reinfection among people who inject drugs.
    J Infect Dis. 2025 May 15:jiaf235. doi: 10.1093.
    >> Share

    February 2025
  12. GONZALEZ-SERNA A, Corma-Gomez A, Cano M, Ricardo RS, et al
    Influence of Cellular Aging on Liver Stiffness in HCV Patients Achieving Sustained Viral Response.
    J Infect Dis. 2025 Feb 19:jiaf087. doi: 10.1093.
    >> Share

    December 2024
  13. WANG J, Genberg BL, Feder K, Kirk GD, et al
    Impact of pandemic-induced service disruptions and behavioral changes on HCV and HIV transmission amongst people who inject drugs: a modeling study.
    J Infect Dis. 2024 Dec 6:jiae599. doi: 10.1093.
    >> Share

  14. SACHITHANANDHAM J, Leep-Lazar J, Quinn J, Bowden K, et al
    Direct acting antivirals eradicate HCV from the liver quickly in people with HIV but do not fully reverse immune activation.
    J Infect Dis. 2024 Dec 4:jiae598. doi: 10.1093.
    >> Share

    October 2024
  15. TRUSCELLO E, Wang S, Young J, Sebastiani G, et al
    Changes in hepatic steatosis before and after direct acting antiviral treatment in people living with HIV and Hepatitis C coinfection.
    J Infect Dis. 2024 Oct 17:jiae487. doi: 10.1093.
    >> Share

    May 2024
  16. GRUDDA T, Thomas DL, Kirk GD, Mehta SH, et al
    Hepatitis B virus DNA and RNA persist in liver after serologic recovery in persons with hepatitis C virus.
    J Infect Dis. 2024 May 23:jiae248. doi: 10.1093.
    >> Share

  17. MBISA JL, Lapp Z, Bibby DF, Phillips LT, et al
    Identification of two novel subtypes of hepatitis C virus genotype 8 and a potential new genotype successfully treated with direct acting antivirals.
    J Infect Dis. 2024 May 8:jiae253. doi: 10.1093.
    >> Share

    April 2024
  18. SELVAMANI SP, Khan A, Tay ESE, Garvey M, et al
    Hepatitis B virus and hepatitis C virus affect mitochondrial function through different metabolic pathways, explaining virus-specific clinical features of chronic hepatitis.
    J Infect Dis. 2024 Apr 24:jiae210. doi: 10.1093.
    >> Share

    March 2024
  19. WHITTAKER R, Midtbo JE, Klovstad H
    Monitoring progress towards the elimination of hepatitis C as a public health threat in Norway: a modelling study among people who inject drugs and immigrants.
    J Infect Dis. 2024 Mar 27:jiae147. doi: 10.1093.
    >> Share

  20. KAMILI S, Wester C
    Advancing diagnosis of current HCV infection: A key to hepatitis C elimination in the United States.
    J Infect Dis. 2024 Mar 11:jiae127. doi: 10.1093.
    >> Share

  21. ASLANIKASHVILI A, Rylander C, Manjavidze T, Gamkrelidze A, et al
    Relationship between hepatitis C infection and treatment status and COVID-19-related hospitalizations in Georgia.
    J Infect Dis. 2024 Mar 1:jiae103. doi: 10.1093.
    >> Share

    February 2024
  22. TU T, Ajoyan H, Nur Umami R, Veeraraghavan V, et al
    Inhibition of cellular factor TM6SF2 suppresses secretion pathways of Hepatitis B, Hepatitis C and Hepatitis D viruses.
    J Infect Dis. 2024 Feb 26:jiae098. doi: 10.1093.
    >> Share

  23. COLLAZOS J, Asensi V
    Non-invasive liver fibrosis markers in the evaluation of fibrosis regression after direct-acting antiviral (DAA) therapy.
    J Infect Dis. 2024 Feb 23:jiae095. doi: 10.1093.
    >> Share

    October 2023
  24. IVANOVA REIPOLD E, Shilton S, Donolato M, Fernandez Suarez M, et al
    Molecular point of care testing for hepatitis C: available technologies, pipeline and promising future directions.
    J Infect Dis. 2023 Oct 28:jiad463. doi: 10.1093.
    >> Share

  25. FELD JJ
    What is needed to move toward single-step diagnosis of current HCV infection?
    J Infect Dis. 2023 Oct 13:jiad453. doi: 10.1093.
    >> Share

  26. FALADE-NWULIA O, Lesko CR, Fojo AT, Keruly JC, et al
    Hepatitis C treatment in people living with HIV: Potential to eliminate disease and disparity.
    J Infect Dis. 2023 Oct 5:jiad433. doi: 10.1093.
    >> Share

    September 2023
  27. FRICKER GP, Ghany MG, Mera J, Pinsky BA, et al
    Tools Needed to Support Same-day Diagnosis and Treatment of Current Hepatitis C Infection.
    J Infect Dis. 2023 Sep 22:jiad177. doi: 10.1093.
    >> Share

  28. CARTWRIGHT EJ, Patel PR
    Opportunities for enhanced prevention and control of hepatitis C through improved screening and testing efforts.
    J Infect Dis. 2023 Sep 22:jiad199. doi: 10.1093.
    >> Share

  29. JOHNSON LN, Gaynor AM, Wroblewski K, Buss SN, et al
    Maximizing Reflexive HCV RNA Testing of HCV Antibody-Reactive Samples Within United States Public Health Laboratories.
    J Infect Dis. 2023 Sep 22:jiad191. doi: 10.1093.
    >> Share

  30. TERRAULT N
    Down-Classification of Hepatitis C Virus Diagnostics: Implications for Screening and Diagnosis.
    J Infect Dis. 2023 Sep 22:jiad299. doi: 10.1093.
    >> Share

  31. PAGE K, Feinberg J
    What Hepatitis C (HCV) diagnostic tools are needed to advance diagnosis of current HCV infection in outreach settings and in a non-clinical setting?
    J Infect Dis. 2023 Sep 22:jiad269. doi: 10.1093.
    >> Share

  32. HANDANAGIC S, Shadaker S, Drobeniuc J, Tsereteli M, et al
    Lessons learned from global hepatitis C elimination programs.
    J Infect Dis. 2023 Sep 22:jiad198. doi: 10.1093.
    >> Share

  33. CHIEN RN, Lu SN, Hui-Min Wu G, Yang WW, et al
    Policy and Strategy for Hepatitis C Virus Elimination at the National Level: Experience in Taiwan.
    J Infect Dis. 2023;228.
    >> Share

  34. KONDILI LA, Craxi L, Nava F, Babudieri S, et al
    From Prioritization to Universal Treatment: Successes and Challenges of Hepatitis C Virus Elimination in Italy.
    J Infect Dis. 2023;228.
    >> Share

  35. AARON A, Zhong H, Hiebert L, Zhuo Y, et al
    Hepatitis C Elimination in Moldova Is Feasible and Cost-Saving: A Modeling Study.
    J Infect Dis. 2023;228.
    >> Share

  36. WASITTHANKASEM R, Wanlapakorn N, Pimsing N, Posuwan N, et al
    Simplified Test-to-Treat Strategy for Hepatitis C in Thailand: The Phetchabun Model.
    J Infect Dis. 2023;228.
    >> Share

  37. PRZYBYSZEWSKI EM, Chung RT
    Unmet Needs in the Post-Direct-Acting Antiviral Era: Hepatocarcinogenesis After Hepatitis C Virus Eradication.
    J Infect Dis. 2023;228.
    >> Share

  38. HUANG CF, Chen GJ, Hung CC, Yu ML, et al
    HCV Microelimination for High-risk Special Populations.
    J Infect Dis. 2023;228.
    >> Share

  39. ADDA D, James C, Peck R, Ali M, et al
    The Role of Nonprofit and Nongovernmental Organizations and People With Viral Hepatitis on the Path Toward Hepatitis C Virus Elimination.
    J Infect Dis. 2023;228.
    >> Share

  40. UMUTESI J, Yu ML, Lesi O, Ward JW, et al
    Strategies for Removal of Barriers to Hepatitis C Elimination in Sub-Saharan Africa.
    J Infect Dis. 2023;228.
    >> Share

  41. SPAULDING AC, Kennedy SS, Osei J, Sidibeh E, et al
    Estimates of Hepatitis C Seroprevalence and Viremia in State Prison Populations in the United States.
    J Infect Dis. 2023;228.
    >> Share

  42. QURESHI H, Mahmood H, Sabry A, Hermez J, et al
    Barriers and Strategies for Hepatitis B and C Elimination in Pakistan.
    J Infect Dis. 2023;228.
    >> Share

    July 2023
  43. POWELL JG, Goble SR, Debes JD
    Re-vaccination For Hepatitis B in Previous Non-Responders Following Hepatitis C Eradication.
    J Infect Dis. 2023 Jul 31:jiad301. doi: 10.1093.
    >> Share

  44. FIERER DS, Schinkel J
    Redefining the Paradigm: The Role of Sexual Networks and Sexualized Drug Use in the Transmission of HCV Among Men Who Have Sex with Men.
    J Infect Dis. 2023 Jul 24:jiad265. doi: 10.1093.
    >> Share

    June 2023
  45. ARTENIE A, Stone J, Facente SN, Fraser H, et al
    Impact of HCV Testing and Treatment on HCV Transmission Among Men Who Have Sex With Men and Who Inject Drugs in San Francisco: A Modelling Analysis.
    J Infect Dis. 2023 Jun 24:jiad169. doi: 10.1093.
    >> Share

    March 2023
  46. GAMKRELIDZE A, Shadaker S, Tsereteli M, Alkhazashvili M, et al
    Nationwide hepatitis C serosurvey and progress towards HCV elimination in the country of Georgia, 2021.
    J Infect Dis. 2023 Mar 18:jiad064. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016